close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about HOTH

Recent news which mentions HOTH

< Previous 1 2 3 4 5 6 Next >
45 Biggest Movers From Yesterday
Tickers AACG ABCM AFI AGFY
Tags MRAM HLGN HRTG
From Benzinga
EXCLUSIVE: Hoth Therapeutics Speaks To Benzinga As Stock Spikes Over 90% On Newly Released Proof-Of-Concept Data
Tickers HOTH
Tags Exclusives Benzinga Biotech
From Benzinga
HOTH Stock Alert: Why Is Hoth Therapeutics Skyrocketing Today?
Tickers HOTH
Tags Market News Today's Market HOTH
From InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
Tickers ARAV AVRO CLBS GNPX
Tags ITCI GNPX AVRO
From Benzinga
Why Hoth Therapeutics Stock Is Soaring Today?
Tickers HOTH
Tags Biotech why it's moving Benzinga
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Tickers ABCM ALNA AVRO BFRI
Tags VALN IMMX Pre/Market Outlook
From Benzinga
Hoth Therapeutics Announces HT-ALZ Therapeutic Shows Positive Results - Reduce Amyloid β in Alzheimer's Disease
Tickers HOTH
Tags Benzinga Hoth Therapeutics Biotech
From Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Tickers DFFN DMTK EDAP FWBI
Tags Movers PALI Market News
From Benzinga
Hoth Therapeutics Announces Submission of Orphan Designation Application for HT-KIT to Treat Mastocytosis
Tickers HOTH
Tags Biotech HOTH Benzinga
From Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Tickers ACAD AQB ARTL BDSI
Tags NVIV CTMX ACAD
From Benzinga
Hoth Therapeutics Reports Finishing Up a Busy Year of Research Across its Portfolio of Drug Candidates
Tickers HOTH
Tags Biotech Hoth Therapeutics Benzinga
From Benzinga
EXCLUSIVE: Hoth Therapeutics Gives Cannabinoid-Based Lupus Candidate Back To Zylö
Tickers HOTH
Tags Health Care Market News Penny Stocks
From Benzinga
Early Clinical Data Suggest This New Lotion Could Offer Best-In-Class Eczema Treatment and Infection Prevention, According to Hoth Therapeutics
Tickers ABBV AMGN BIIB HOTH
Tags Penny Stocks HOTH ABBV
From Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Tickers ALRN ATNF BFRI CALA
Tags ROIV BFRI CALA
From Benzinga
EXCLUSIVE: Hoth Therapeutics Starts Dosing In Second Cohort Of Atopic Dermatitis Trial With BioLexa
Tickers HOTH
Tags Benzinga Exclusives Biotech
From Benzinga
Hoth Inks Research Agreement With North Carolina State University For Study of Preclinical Candidate To Treat Mast Cell Cancers
Tickers HOTH
Tags Market News Penny Stocks HOTH
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Tickers APTX CFMS EVFM HOTH
Tags RPRX NDRA Pre/Market Outlook
From Benzinga
Hoth Therapeutics Enters Into Agreements with WuXi STA; Attempts to Get New Cancer Treatment Closer to Clinical Trials
Tickers HOTH
Tags Market News HOTH Penny Stocks
From Benzinga
This Company Says Its New Topical Therapy Trials Bringing Hope to People Exposed to Biofilm Bacteria
Tickers ABBV AMGN BIIB HOTH
Tags Partner Content Biotech Benzinga
From Benzinga
Clinical-Stage Biopharmaceutical Company HOTH Says It Is on a Mission to Develop Next-Generation Therapeutics to Meet Patient Needs
Tickers ABBV HOTH JNJ PFE
Tags Benzinga Biotech Partner Content
From Benzinga
Hoth Therapeutics Says the Possibilities Could Be Endless
Tickers HOTH
Tags Market News Biotech Emerging Markets
From Benzinga
Hoth Therapeutics Receives Approval to Commence Cohort 2 in Clinical Trial of BioLexa for the Treatment of Atopic Dermatitis in Humans
Tickers HOTH
Tags General Partner Content Press Releases
From Benzinga
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
Tickers ADVM AFIB AGTC AKYA
Tags Offerings SPPI LIXT
From Benzinga
Alkido Pharma Trading 30% Below Cash Value Despite Positive Indications
Tickers AIKI DATS HOTH
Tags Benzinga Biotech AIKI
From Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today